Reader variability and validation of the Timika X-ray score during treatment of pulmonary tuberculosis

Int J Tuberc Lung Dis. 2016 Oct;20(10):1358-1363. doi: 10.5588/ijtld.16.0186.

Abstract

Setting: Chest radiographs (CXRs) are widely used for diagnosing pulmonary TB and assessing response to therapy. The Timika X-ray score has been proposed as a tool for measuring disease severity and predicting treatment outcome.

Objective: To evaluate inter- and intra-reader agreement of Timika scores and assess the ability of the score to predict microbiologic outcome at 2 months.

Design: Analytical validation study. Disease severity was measured by two readers using pretreatment radiographs and follow-up films taken at 2, 6 and 12 months after the start of treatment among 110 human immunodeficiency virus negative adults with pulmonary TB. One fourth of the films were reread to assess intra-reader agreement.

Results: The two-component Timika score had high inter- and intra-reader agreement (intraclass correlation (ICC)inter = 75%, ICCintra > 0.81). Baseline Timika score was associated with positive month 2 smear (P = 0.0004) and culture status (P = 0.03). The average Timika score declined significantly over the course of successful treatment.

Conclusion: The Timika score showed good inter- and intra-reader agreement and a significant association with microbiological outcomes after 2 months of treatment. The results of this study strengthen the evidence supporting the use of the Timika score for measuring disease severity on CXR.

Publication types

  • Validation Study

MeSH terms

  • Adult
  • Antitubercular Agents / therapeutic use
  • Body Mass Index
  • Body Weight
  • Cohort Studies
  • Female
  • Follow-Up Studies
  • Humans
  • Lost to Follow-Up
  • Male
  • Observer Variation*
  • Prognosis
  • Radiography / methods*
  • Reproducibility of Results
  • Severity of Illness Index
  • Sputum / microbiology
  • Treatment Outcome
  • Tuberculosis, Pulmonary / diagnostic imaging*
  • Tuberculosis, Pulmonary / drug therapy
  • X-Rays
  • Young Adult

Substances

  • Antitubercular Agents